POAI Logo 011319 (002).jpg
Predictive Oncology Adjourns Annual Meeting of Stockholders to December 30, 2021
December 27, 2021 17:10 ET | Predictive Oncology Inc.
MINNEAPOLIS, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...
POAI Logo 011319 (002).jpg
Predictive Oncology – Year-end Shareholder Update!
December 21, 2021 08:30 ET | Predictive Oncology Inc.
EAGAN, Minn., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology, (POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to develop personalized cancer therapies, is...
Pamela Bush
Pamela Bush, Ph.D., MBA, Joins Predictive Oncology as SVP of Strategic Sales and Business Development
December 07, 2021 08:30 ET | Predictive Oncology Inc.
EAGAN, Minn., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology, (POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to develop personalized cancer therapies,...
POAI Logo 011319 (002).jpg
Predictive Oncology Acquires zPREDICTA, Inc.
December 01, 2021 08:30 ET | Predictive Oncology Inc.
EAGAN, Minn., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology, (POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to develop personalized cancer therapies,...
POAI Logo 011319 (002).jpg
Predictive Oncology Reports Third Quarter Financial Results
November 10, 2021 17:15 ET | Predictive Oncology Inc.
EAGAN, Minn., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Results from the third quarter show strong potential for future growth, said Predictive Oncology (Nasdaq: POAI) today, announcing financial results...
POAI Logo 011319 (002).jpg
Predictive Oncology Launches Website Highlighting AI-Powered Cancer Research Advancements
October 19, 2021 08:30 ET | Predictive Oncology Inc.
MINNEAPOLIS, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology, an oncology and cancer research company using big data and machine learning to improve pharmaceutical development and predictive...
POAI Logo 011319 (002).jpg
Predictive Oncology Inc. Announces Newest Board Member
September 15, 2021 08:30 ET | Predictive Oncology Inc.
MINNEAPOLIS, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...
POAI Logo 011319 (002).jpg
Predictive Oncology Announces Results of Charter Amendment Proposal at Special Meeting
August 18, 2021 13:45 ET | Predictive Oncology Inc.
MINNEAPOLIS, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...
POAI Logo 011319 (002).jpg
Predictive Oncology Reports Financial Results for Quarter Ended June 30, 2021, and Provides Business Update
August 11, 2021 17:15 ET | Predictive Oncology Inc.
MINNEAPOLIS, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...
POAI Logo 011319 (002).jpg
Predictive Oncology Adjourns Special Meeting of Stockholders
August 11, 2021 08:30 ET | Predictive Oncology Inc.
MINNEAPOLIS, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug...